EUVIMEDObjevte EUVIMED
Open access

GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction

Jingtong Zeng, Xianjie Li, Yifan Zhang, Bo Zhang, Hanqing Wang, Shihao Bao, Lingling Zu, Hao Zhang, Yuan Cheng, Quanying Tang, Xiaohong Xu, Song Xu and 1 more

Aging · 2024

DOI: 10.18632/aging.205774 ↗

At a glance

Journal article in Aging, 2024. Written by Jingtong Zeng and 12 co-authors. Institution: Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China. Major MEDLINE topics: Biomarkers, Tumor, Neoplasms, Immunotherapy, Connexins. Cited 4 times so far (Crossref); 27 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

BACKGROUND: A wide range of connexins are situated between normal-normal cells, cancer-cancer cells, and cancer-normal cells. Abnormalities in connexin expression are typically accompanied by cancer development; however, no systematic studies have examined the role of Gap Junction Protein Beta 3 (GJB3) in the context of tumor progression and immunity, especially when considering a broad range of cancer types. METHODS: In this study, data on GJB3 expression were gathered from Genotype-Tissue Expression, Cancer Cell Line Encyclopedia, and The Cancer Genome Atlas databases. Then, we analyzed the relationship between GJB3 expression and tumor characteristics. In vitro experiments using colony formation, EdU, CCK8, transwell migration assays, immunohistochemistry and western blot were performed to investigate the function of GJB3 in tumor progression of various cell lines. A drug sensitivity analysis of GJB3 was performed using the Genomics of Drug Sensitivity in Cancer database. RESULT: Our findings demonstrate that GJB3 is widely expressed in various cancers and correlates significantly with disease stages, patient survival, immunotherapy response, and pharmaceutical guidance. Additionally, GJB3 plays a role in different cancer pathways, as well as in different immune and molecular subtypes of cancer. Co-expression of GJB3 with immune checkpoint genes was observed. Further experiments showed that knockdown of GJB3 inhibited the PI3K/AKT pathway and resulted in reduced proliferation, migration, and viability of different cancer cells. CONCLUSION: Overall, GJB3 shows potential as a molecular biomarker and therapeutic target for various cancers, particularly lung adenocarcinomas, mesothelioma, pancreatic adenocarcinoma. Thus, GJB3 may represent a new therapeutic target for a wide range of cancers.

Subjects

MeSH terms (MEDLINE)

Biomarkers, TumorNeoplasmsImmunotherapyConnexinsHumansPrognosisCell Line, TumorGene Expression Regulation, NeoplasticCell ProliferationCell Movement

Author keywords

GJB3 (Cx31) geneLUADTCGAconnexinpan-cancer

Substances

Biomarkers, TumorConnexinsGJB3 protein, human

Authors and institutions

  • Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Colleges of Nursing, Tianjin Medical University, Tianjin, China.

Cite

APA

Zeng, J., Li, X., Zhang, Y., Zhang, B., Wang, H., Bao, S., Zu, L., Zhang, H., Cheng, Y., Tang, Q., Xu, X., Xu, S., & Song, Z. (2024). GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction. Aging. https://doi.org/10.18632/aging.205774

Vancouver

Zeng J, Li X, Zhang Y, Zhang B, Wang H, Bao S, et al. GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction. Aging. 2024. doi:10.18632/aging.205774

BibTeX
@article{Zeng2024,
  author = {Zeng, Jingtong and Li, Xianjie and Zhang, Yifan and Zhang, Bo and Wang, Hanqing and Bao, Shihao and Zu, Lingling and Zhang, Hao and Cheng, Yuan and Tang, Quanying and Xu, Xiaohong and Xu, Song and Song, Zuoqing},
  title = {GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205774}
}
Start for free →